T2B! Immunity Against SARS-CoV-2 Study Group

Independent

SCHOLARLY PAPERS

1

DOWNLOADS

14

TOTAL CITATIONS

0

Scholarly Papers (1)

1.

Disease Activity after Sars-Cov-2 Delta and Omicron Breakthrough Infections in Patients with Immune-Mediated Inflammatory Diseases

Number of pages: 15 Posted: 15 Jul 2024
Amsterdam UMC - Department of Neurology and Neurophysiology, Amsterdam UMC - Department of Neurology and Neurophysiology, Amsterdam UMC - Department of Neurology and Neurophysiology, Amsterdam UMC, Vrije Universiteit - Department of Neurology, Amsterdam UMC, Vrije Universiteit - Department of Neurology, University of Amsterdam - Department of Gastroenterology and Hepatology, University of Amsterdam - Department of Rheumatology and Clinical Immunology, University of Amsterdam - Department of Neurology, University of Amsterdam - Department of Neurology, University of Amsterdam - Amsterdam Rheumatology and Immunology Centre, Location Reade, University of Amsterdam - Amsterdam Rheumatology and Immunology Centre, affiliation not provided to SSRN, University of Amsterdam - Department of Gastroenterology and Hepatology, University of Amsterdam - University Medical Center, University of Amsterdam - Department of Dermatology, University of Amsterdam - Department of Dermatology, University of Amsterdam - Department of Dermatology, University of Amsterdam - Department of Dermatology, University of Amsterdam - Department of Dermatology, University of Amsterdam - Department of Internal Medicine, University of Amsterdam - Department of Internal Medicine, University of Amsterdam - Department of Internal Medicine, VU University Medical Center - Amsterdam Rheumatology and Immunology Center, University of Amsterdam - Department of Clinical Immunology and Rheumatology, University of Amsterdam - Department of Clinical Immunology and Rheumatology, National Institute for Public Health and the Environment (RIVM) - Centre for Infectious Disease Control, National Institute for Public Health and the Environment (RIVM) - Centre for Infectious Disease Control, University of Groningen - University Medical Center Groningen (UMCG), University of Groningen - Department of Rheumatology and Clinical Immunology, University of Groningen - Department of Dermatology, Leiden University - Department of Neurology, Leiden University - Department of Neurology, Leiden University - Department of Rheumatology, Leiden University - Department of Rheumatology, Leiden University - Department of Rheumatology, Leiden University - Department of Nephrology, Maastricht University - Division of Nephrology and Clinical Immunology, Department of Immunology, Maastricht UMC+, Erasmus University Rotterdam (EUR) - Department of Neurology, Erasmus University Rotterdam (EUR) - Department of Neurology, Erasmus University Rotterdam (EUR) - Department of Neurology, Erasmus University Rotterdam (EUR) - Department of Dermatology, Erasmus University Rotterdam (EUR) - Department of Dermatology, Utrecht University - Brain Center Rudolf Magnus, Utrecht University - University Medical Center (Utrecht), Sanquin Research - Department of Immunopathology, Sanquin Research - Department of Immunopathology, Sanquin Research - Department of Immunopathology, Sanquin Research - Department of Immunopathology, Sanquin Research, Sanquin Research, University of Amsterdam - University Medical Center, Sanquin Research - Department of Immunopathology, Sanquin Research - Department of Immunopathology, University of Amsterdam - Department of Pediatric Immunology, Rheumatology and Infectious Disease, Amsterdam UMC - Department of Neurology and Neurophysiology, Amsterdam UMC - Department of Neurology and Neurophysiology and Independent
Downloads 14 (1,082,311)

Abstract:

Loading...

autoimmune disease, COVID-19, Disease Activity, SARS-CoV-2 breakthrough infections